Neogen (NEOG) EBITDA Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neogen | 1.94 Bn | 1.78 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -1,508.00 |
| Nov 30, 2025 | -1,913.00 |
| Aug 31, 2025 | -590.00 |
| May 31, 2025 | 7,570.00 |
| Feb 28, 2025 | -1,062.00 |
| Nov 30, 2024 | -21,477.00 |
| Aug 31, 2024 | -1,500.00 |
| May 31, 2024 | -3,760.00 |
| Feb 29, 2024 | -973.00 |
| Nov 30, 2023 | -1,074.00 |
| Aug 31, 2023 | -818.00 |
| May 31, 2023 | -868.00 |
| Feb 28, 2023 | -958.00 |
| Nov 30, 2022 | -2,120.00 |
| Aug 31, 2022 | -1,285.00 |
| May 31, 2022 | -635.00 |
| Feb 28, 2022 | -1,126.00 |
| Nov 30, 2021 | -1,234.00 |
| Aug 31, 2021 | -11,237.00 |
| May 31, 2021 | 3,958.00 |
| Feb 28, 2021 | -115.00 |
| Nov 30, 2020 | -162.00 |
| Aug 31, 2020 | -2,169.00 |
| May 31, 2020 | 4,407.00 |
| Feb 29, 2020 | -472.00 |
| Nov 30, 2019 | -189.00 |
| Aug 31, 2019 | -384.00 |
| May 31, 2019 | 72.00 |
| Feb 28, 2019 | -162.00 |
| Nov 30, 2018 | 78.00 |
| Aug 31, 2018 | -467.00 |
| May 31, 2018 | 9.00 |
| Feb 28, 2018 | -216.00 |
| Nov 30, 2017 | -278.00 |
| Aug 31, 2017 | -333.00 |
| May 31, 2017 | 131.00 |
| Feb 28, 2017 | -57.00 |
| Nov 30, 2016 | 376.00 |
| Aug 31, 2016 | 10,885.00 |
| May 31, 2016 | 1,070.00 |
| Feb 29, 2016 | -443.00 |
| Nov 30, 2015 | -356.00 |
| Aug 31, 2015 | -246.00 |